NF-kB p65基因沉默对雌激素诱导的人肝细胞BSEP/NTCP表达的影响

被引:0
作者
谭海燕
机构
[1] 中南大学
关键词
雌激素; 核因子κB; RNA干扰; BSEP; NTCP; 人肝细胞;
D O I
暂无
年度学位
2011
学位类型
硕士
导师
摘要
目的: 通过特异性的siRNA沉默NF-κB p65基因表达,探索其对17β雌二醇(E2)诱导L-02人正常肝细胞中胆盐输出泵(BSEP)、钠-牛磺胆酸共转运子(NTCP)表达的影响。 方法: 1.人肝细胞的培养,Western bloting方法对该细胞中BSEP、NTCP表达阳性的验证。 2.NF-kB siRNA的合成、筛选。应用荧光标记的人工合成NF-kB p65 siRNA序列和LipofectamineTM2000进行转染率的筛选实验。用Real-time PCR进行NF-κB p65-siRNA有效序列的筛选。 3.采用实时荧光定量PCR及Western bloting方法,检测雌激素诱导的人肝细胞NF-kB p65基因沉默前后BSEP、NTCP mRNA及蛋白表达水平,明确NF-kB对人肝细胞中BSEP、NTCP表达的影响。 结果: (1)正常人肝细胞中BSEP及NTCP均有表达 (2)雌激素对肝细胞中NF-κB表达升高及NF-kB siRNA最佳片段的筛选。 NF-κB在500nmol/L E2作用的L-02肝细胞24小时后,其蛋白表达量明显高于对照组,差异有统计学意义(P<0.05);应用转染试剂在同一优化条件下,L-02细胞可成功转染,转染效率达70%。siRNA 1049有最佳沉默NF-kB基因的作用,与空白对照组比较,沉默效果明显(P<0.05),转染24小时以后沉默效率达到70%。NF-κB p65基因表达水平在转染后24小时抑制明显,较阴性对照组及空白对照组有明显差异(P<0.05)。 (3)沉默NF-κB p65表达对雌激素诱导肝细胞中BSEP、NTCP表达增强。 干扰组中BSEP、NTCP mRNA及蛋白表达均高于空白对照组及未干扰组,差异有统计学意义(P<0.05);而空白对照组与未干扰组BSEP及NTCP表达比较差异无统计学意义(P>0.05)。 结论: 1.特异性siRNA可有效下调雌激素诱导的肝细胞中NF-kB的表达 2.通过siRNA沉默NF-kB,可下调雌激素诱导下肝细胞BSEP及NTCP的表达; 3.NF-kB可能参与了E2诱导的肝细胞下调BSEP及NTCP的表达。
引用
收藏
页数:52
共 35 条
[1]
REVIEW: Intrahepatic cholestasis. A puzzling disorder of pregnancy.[J].HUMBERTOREYES.Journal of Gastroenterology and Hepatology.2008, 3
[2]
Oestrogens inhibit interleukin 1β-mediated nitric oxide synthase expression in articular chondrocytes through nuclear factor-κB impairment [J].
Richette, Pascal ;
Dumontier, Marie-France ;
Tahiri, Khadija ;
Widerak, Magdalena ;
Torre, Antoine ;
Benallaloua, Mourad ;
Rannou, Francois ;
Corvol, Marie-Therese ;
Savouret, Jean-Francois .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (03) :345-350
[3]
Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression [J].
Cvoro, A ;
Tzagarakis-Foster, C ;
Tatomer, D ;
Paruthiyil, S ;
Fox, MS ;
Leitman, DC .
MOLECULAR CELL, 2006, 21 (04) :555-564
[4]
Analysis of the effect of tetrahydrobiopterin on PAH gene expression in hepatoma cells [J].
Aguado, C ;
Pérez, B ;
Ugarte, M ;
Desviat, LR .
FEBS LETTERS, 2006, 580 (07) :1697-1701
[5]
Transcription factor cross-talk:: the estrogen receptor and NF-κB [J].
Kalaitzidis, D ;
Gilmore, TD .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2005, 16 (02) :46-52
[6]
CpG inhibits IgE class switch recombination through suppression of NFκB activity, but not through Id2 or Bcl6 [J].
Kusunoki, T ;
Sugai, M ;
Gonda, H ;
Nambu, Y ;
Nagata-Nakajima, N ;
Katakai, T ;
Kusunoki, M ;
Sakamoto, A ;
Takeshisa, TD ;
Nakahata, T ;
Yokota, Y ;
Shimizu, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 328 (02) :499-506
[7]
Dialyzable Leukocyte Extract differentially regulates the production of TNFα, IL-6, and IL-8 in bacterial component-activated leukocytes and endothelial cells [J].
Ojeda, MO ;
van't Veer, C ;
Ortega, CBF ;
Rosainz, MDA ;
Buurman, WA .
INFLAMMATION RESEARCH, 2005, 54 (02) :74-81
[8]
Activation of nuclear factor-κB (NFκB) identifies a high-risk subset of hormone-dependent breast cancers.[J].Yamei Zhou;Serenella Eppenberger-Castori;Corina Marx;Christina Yau;Gary K. Scott;Urs Eppenberger;Christopher C. Benz.International Journal of Biochemistry and Cell Biology.2004, 5
[9]
Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia [J].
Wen, Y ;
Yang, SH ;
Liu, R ;
Perez, E ;
Yi, KD ;
Koulen, P ;
Simpkins, JW .
BRAIN RESEARCH, 2004, 1008 (02) :147-154
[10]
Nuclear factor-κB: a friend or a foe in cancer?.[J].Shishir Shishodia;Bharat B Aggarwal.Biochemical Pharmacology.2004, 6